Developer docs
API playgroundTry for free, no card

Search company profiles

MedShape

Full company profile

uuid000bth9

Namestring
MedShape
Legal namestring
MedShape, Inc.
Company typeenum
Private
Founded yearint
2005
Descriptiontext

MedShape, Inc. is a private medical device company headquartered at 1575 Northside Drive NW, Suite 440, Atlanta, Georgia, that develops and commercializes orthopedic surgical implants based on proprietary shape memory biomaterials. The company targets orthopedic surgeons and healthcare institutions for soft tissue fixation, fracture repair, and joint fusion procedures, including specialized applications such as TTC (tibiotalocalcaneal) fusion. MedShape's product portfolio comprises four core devices: Dynanail, a shape memory nail system; FastForward, a TTC fusion device; Eclipse (also marketed as Exoshape Teno); and Morphix, a shape memory polymer implant. These products leverage a platform technology in which the proprietary biomaterials can transform and adapt inside the body, differentiating them from conventional metallic orthopedic implants.

The company generates revenue through direct enterprise sales of its hardware devices to surgeons and hospitals, primarily in North America. Its go-to-market relies on field sales engagement with surgical professionals supported by content marketing through its corporate website, social media presence across LinkedIn, Twitter, Facebook, Instagram, and YouTube, and a surgeon education platform called MedShape University. Cumulative disclosed funding totals approximately $36.5 million across rounds from 2009 through 2014, with the largest single raise of $11 million in October 2013 and strategic capital from GE Capital in February 2012; no funding rounds have been publicly disclosed since August 2014. MedShape operates with 11-50 employees and competes in the foot and ankle devices market (one of 20+ competitors in a market projected to grow from $5.9B in 2025 to $9.2B by 2034 at ~8% CAGR) and the broader shape memory polymers market (projected to grow from $0.7B in 2025 to $4.0B by 2035 at ~19.6% CAGR), where the biomedical segment leads at approximately 37% share. Recent product launches in 2024-2025 indicate the company remains commercially active despite the long gap in disclosed capital raising.

Short descriptiontext

MedShape is a private Atlanta-based medical device company that develops proprietary shape memory biomaterial implants for orthopedic soft tissue fixation, fracture repair, and joint fusion procedures, serving surgeons and hospitals with four core products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAtlanta, United States
HQ citystring
Atlanta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic medical devices, shape memory biomaterials, soft tissue fixation, fracture management devices, joint fusion implants
Industry2 codes
PRIMARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Orthopedic Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

MedShape generates revenue through the sale of proprietary orthopedic devices made from shape memory biomaterials. Products include DynaNail, FastForward, ExoShaped Teno, Morphix, and Eclipse devices for soft tissue fixation, fracture repair, and joint fusion procedures.

crx.rty.temporary.site
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1dynanail
Description

Shape memory nail product for orthopedic surgery

crx.rty.temporary.site
+3 more records
Core offering1 text field

MedShape develops, manufactures, and markets orthopedic surgical implants made from proprietary shape memory biomaterials. Its portfolio of devices — DynaNail, FastForward, Eclipse (ExoShaped Teno), and Morphix — is sold to orthopedic surgeons and hospitals for soft tissue fixation, fracture repair, and joint fusion procedures, with TTC Fusion Technology highlighted as the latest platform development.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MedShape is an orthopedic device company offering a portfolio of shape memory polymer-based surgical devices. The company provides four core products: Dynanail, FastForward, Eclipse (Exoshape Teno), and Morphix. These devices utilize proprietary shape memory biomaterials that can transform and adapt inside the body, enabling soft tissue fixation, fracture repair, and joint fusions. The products represent a platform of surgical implants based on advanced material technologies rather than traditional metallic or polymeric devices.

Product and service1 record
1DynaNail
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-standing specialist in foot and ankle orthopedics; directly comparable to MedShape's foot/ankle fixation and fusion focus (TTC fusions) and serves the same orthopedic surgeon customer base.

TypeDirect peer
Description

Pure-play foot and ankle orthopedic company with implant and fixation products targeting orthopedic surgeons and hospitals. Comparable niche focus, customer type, and small-bone procedural orientation.

3Paragon 28
TypeDirect peer
Description

Specialty foot and ankle orthopedic device company with broad fixation and fusion portfolios. Comparable in procedure focus (including TTC fusions), customer base, and competitive positioning vs. MedShape.

TypeBroad incumbent
Description

Large orthopedic and sports medicine device company with broad fixation and soft tissue products sold through a deep surgeon sales force. Overlaps with MedShape in soft tissue fixation and orthopedic trauma but operates at significantly greater scale.

TypeBroad incumbent
Description

Multi-specialty orthopedic and medical device leader with foot/ankle, extremities, trauma, and biomaterials franchises. Comparable end-customers (orthopedic surgeons/hospitals) and overlapping product categories (nails, plates, fixation).

TypeBroad incumbent
Description

Orthopedic and regenerative tissue company with extremities and specialty fixation products, including biomaterials-based implants. Comparable in biomaterials positioning and orthopedic surgeon channel.

TypeDirect peer
Description

Orthopedic extremities company with plates, screws, and small-bone fixation devices. Direct overlap with MedShape's fractures/extremities fixation focus and similar GTM through surgeon and hospital channels.

TypeBroad incumbent
Description

Global orthopedic and sports medicine major with trauma, extremities, and arthroplasty portfolios. Comparable end-customer and overlapping fixation/biomaterial device categories.

TypeBroad incumbent
Description

World's largest orthopedic trauma and extremities business with nails, plates, screws, and foot/ankle products. Direct category overlap and same hospital procurement customers.

TypeEmerging player
Description

Developer of shape-memory polymers and biomedical materials, directly named alongside MedShape in shape-memory polymer market analyses with overlapping 2024-2025 product launches. Comparable in shape-memory IP focus rather than end-device scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MedShape

Orthopedic Medical Devicesmedshapesolutions.com

MedShape is a private Atlanta-based medical device company that develops proprietary shape memory biomaterial implants for orthopedic soft tissue fixation, fracture repair, and joint fusion procedures, serving surgeons and hospitals with four core products.

What MedShape does

MedShape, Inc. is a private medical device company headquartered at 1575 Northside Drive NW, Suite 440, Atlanta, Georgia, that develops and commercializes orthopedic surgical implants based on proprietary shape memory biomaterials. The company targets orthopedic surgeons and healthcare institutions for soft tissue fixation, fracture repair, and joint fusion procedures, including specialized applications such as TTC (tibiotalocalcaneal) fusion. MedShape's product portfolio comprises four core devices: Dynanail, a shape memory nail system; FastForward, a TTC fusion device; Eclipse (also marketed as Exoshape Teno); and Morphix, a shape memory polymer implant. These products leverage a platform technology in which the proprietary biomaterials can transform and adapt inside the body, differentiating them from conventional metallic orthopedic implants.

The company generates revenue through direct enterprise sales of its hardware devices to surgeons and hospitals, primarily in North America. Its go-to-market relies on field sales engagement with surgical professionals supported by content marketing through its corporate website, social media presence across LinkedIn, Twitter, Facebook, Instagram, and YouTube, and a surgeon education platform called MedShape University. Cumulative disclosed funding totals approximately $36.5 million across rounds from 2009 through 2014, with the largest single raise of $11 million in October 2013 and strategic capital from GE Capital in February 2012; no funding rounds have been publicly disclosed since August 2014. MedShape operates with 11-50 employees and competes in the foot and ankle devices market (one of 20+ competitors in a market projected to grow from $5.9B in 2025 to $9.2B by 2034 at ~8% CAGR) and the broader shape memory polymers market (projected to grow from $0.7B in 2025 to $4.0B by 2035 at ~19.6% CAGR), where the biomedical segment leads at approximately 37% share. Recent product launches in 2024-2025 indicate the company remains commercially active despite the long gap in disclosed capital raising.

MedShape firmographics

Firmographics
Name
MedShape
Legal name
MedShape, Inc.
Website
https://medshapesolutions.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
MedShape is a private Atlanta-based medical device company that develops proprietary shape memory biomaterial implants for orthopedic soft tissue fixation, fracture repair, and joint fusion procedures, serving surgeons and hospitals with four core products.
Ownership category
akta.pro rank

MedShape industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Orthopedic medical devices
  • Shape memory biomaterials
  • Soft tissue fixation
  • Fracture management devices
  • Joint fusion implants

Where MedShape is headquartered

Location

Headquarters

HQ city
Atlanta
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MedShape business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Medical Device Sales: MedShape generates revenue through the sale of proprietary orthopedic devices made from shape memory biomaterials. Products include DynaNail, FastForward, ExoShaped Teno, Morphix, and Eclipse devices for soft tissue fixation, fracture repair, and joint fusion procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

MedShape product offering

Product offering

Core offering

MedShape develops, manufactures, and markets orthopedic surgical implants made from proprietary shape memory biomaterials. Its portfolio of devices — DynaNail, FastForward, Eclipse (ExoShaped Teno), and Morphix — is sold to orthopedic surgeons and hospitals for soft tissue fixation, fracture repair, and joint fusion procedures, with TTC Fusion Technology highlighted as the latest platform development.

Product overview

MedShape is an orthopedic device company offering a portfolio of shape memory polymer-based surgical devices. The company provides four core products: Dynanail, FastForward, Eclipse (Exoshape Teno), and Morphix. These devices utilize proprietary shape memory biomaterials that can transform and adapt inside the body, enabling soft tissue fixation, fracture repair, and joint fusions. The products represent a platform of surgical implants based on advanced material technologies rather than traditional metallic or polymeric devices.

Differentiator

Problem solved

Functional benefit

Brands

  • dynanail: Shape memory nail product for orthopedic surgery
  • fastforward
  • eclipse
  • morphix

Products and services

  • DynaNail

Companies that use MedShape

Customer profile

Segments1 record

Ideal customer profiles1 record

MedShape technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

MedShape partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

MedShape competitors and assessment

Company assessment

Direct peers

  • Wright Medical Group (now Stryker): Long-standing specialist in foot and ankle orthopedics; directly comparable to MedShape's foot/ankle fixation and fusion focus (TTC fusions) and serves the same orthopedic surgeon customer base.
  • Treace Medical Concepts: Pure-play foot and ankle orthopedic company with implant and fixation products targeting orthopedic surgeons and hospitals. Comparable niche focus, customer type, and small-bone procedural orientation.
  • Paragon 28: Specialty foot and ankle orthopedic device company with broad fixation and fusion portfolios. Comparable in procedure focus (including TTC fusions), customer base, and competitive positioning vs. MedShape.
  • Acumed: Orthopedic extremities company with plates, screws, and small-bone fixation devices. Direct overlap with MedShape's fractures/extremities fixation focus and similar GTM through surgeon and hospital channels.

Broad incumbents

  • Arthrex: Large orthopedic and sports medicine device company with broad fixation and soft tissue products sold through a deep surgeon sales force. Overlaps with MedShape in soft tissue fixation and orthopedic trauma but operates at significantly greater scale.
  • Stryker Corporation: Multi-specialty orthopedic and medical device leader with foot/ankle, extremities, trauma, and biomaterials franchises. Comparable end-customers (orthopedic surgeons/hospitals) and overlapping product categories (nails, plates, fixation).
  • Integra LifeSciences: Orthopedic and regenerative tissue company with extremities and specialty fixation products, including biomaterials-based implants. Comparable in biomaterials positioning and orthopedic surgeon channel.
  • Smith+Nephew: Global orthopedic and sports medicine major with trauma, extremities, and arthroplasty portfolios. Comparable end-customer and overlapping fixation/biomaterial device categories.
  • DePuy Synthes (Johnson & Johnson): World's largest orthopedic trauma and extremities business with nails, plates, screws, and foot/ankle products. Direct category overlap and same hospital procurement customers.

Emerging players

  • Cornerstone Research Group: Developer of shape-memory polymers and biomedical materials, directly named alongside MedShape in shape-memory polymer market analyses with overlapping 2024-2025 product launches. Comparable in shape-memory IP focus rather than end-device scale.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

MedShape social profiles

Digital presence

MedShape financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MedShape leadership team

Management profile

Number of profiles

MedShape funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MedShape M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedShape

What does MedShape do?

MedShape develops, manufactures, and markets orthopedic surgical implants made from proprietary shape memory biomaterials. Its portfolio of devices — DynaNail, FastForward, Eclipse (ExoShaped Teno), and Morphix — is sold to orthopedic surgeons and hospitals for soft tissue fixation, fracture repair, and joint fusion procedures, with TTC Fusion Technology highlighted as the latest platform development.

Is MedShape a public or private company?

MedShape is a private company. It is classified as unknown and is currently operating.

When was MedShape founded?

MedShape was founded in 2005. It employs 1 to 10 people.

Where is MedShape based?

MedShape is headquartered in Atlanta, United States, in the North America region.

How does MedShape make money?

One revenue line is on record: medical Device Sales.

Who are MedShape's main competitors?

Direct peers on record are Wright Medical Group (now Stryker), Treace Medical Concepts, Paragon 28 and Acumed. Broad incumbents are Arthrex, Stryker Corporation, Integra LifeSciences, Smith+Nephew and DePuy Synthes (Johnson & Johnson). Cornerstone Research Group is listed as an emerging player.

Does MedShape have an API?

No public API is recorded for MedShape.

What industry is MedShape in?

MedShape's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comShape-Memory Polymers Market to Reach USD 4.0 Billion by 2035, Driven by Biomedical Innovation, Aerospace Applications, and Smart Material AdvancementsMarketGenics Global Research released a comprehensive analysis projecting the global shape-memory polymers market to grow from USD 0.7 billion in 2025 to USD 4.0 billion by 2035, representing a CAGR of 19.6%. The biomedical industry currently leads the market at approximately 37% share, while Asia Pacific dominates regionally with 60-65% market share and growth exceeding 21% CAGR, driven by rapid industrialization and expanding healthcare infrastructure. Strategic developments include Boeing's 2023 partnership on SMP-based morphing wing technology, alongside new product launches by MedShape and Cornerstone Research Group in 2024-2025.PR NewswireMedShape And CurveBeam Announce Initiation of Joint Prospective Clinical StudyMedShape, Inc. (recently acquired by DJO®) and CurveBeam jointly announced the initiation of a prospective clinical study with the Orthopaedic Foot & Ankle Center in Dublin, Ohio, to evaluate MedShape's DynaNail TTC Fusion System using CurveBeam's LineUP weight-bearing CT system in 45 patients undergoing tibiotalocalcaneal arthrodesis. The study aims to correlate the NiTiNOL element recovery and three-dimensional fusion assessment with patient functional improvement through serial CT scans over 12 post-operative months. Both companies will present details of the study at the American College of Foot & Ankle Surgeons Annual Scientific Conference in Las Vegas.Business Wire BlogDJO® Acquires MedShape, Inc.DJO completed the acquisition of MedShape, a privately held orthopedic device company founded in 2005. MedShape provides foot and ankle surgical solutions using shape memory alloy and polymer technologies, including the DynaNail TTC Fusion System. The acquisition expands DJO's foot and ankle portfolio, with the market expected to reach $1.58B by 2025.PR NewswireMedShape Announces Commercial Launch of DynaNail Mini® for Medial Column FusionMedShape, Inc. announced the full market release of its DynaNail Mini® Fusion System for medial column fusion procedures to treat Charcot Foot and severe midfoot conditions. The device features the company's patented superelastic nickel titanium (NiTiNOL) technology and is the first internal fixation device specifically designed for medial column fusion that maintains active post-operative compression to promote bone healing and joint stability. This launch expands the product beyond its 2019 limited release for subtalar fusion, with new longer lengths (110-140 mm) now available to provide greater stability across the midfoot anatomy.PR NewswireMedShape Receives Unique ICD-10-PCS Codes for Sustained Compression Internal Fixation DeviceMedShape announced that the U.S. Centers for Medicare & Medicaid Services (CMS) issued unique ICD-10-PCS codes for its DynaNail and DynaNail Mini sustained compression internal fixation devices. This designation distinguishes MedShape's products from traditional static fixation systems, which cannot maintain compression during bone healing. The new codes, effective October 1st, allow healthcare providers to specifically track the utilization and outcomes of these advanced NiTiNOL technologies.PR NewswireMedShape Announces Commercial Launch of the DynaClip Forte® NiTiNOL Bone Fixation SystemMedShape, Inc. announced the full commercial launch of its DynaClip Forte NiTiNOL Bone Fixation System in the United States on September 8, 2020. The device features a patented four-leg inline design with superelastic nickel titanium technology, specifically engineered for high load-bearing foot and ankle applications such as first tarsometatarsal (Lapidus) fusion procedures. The launch expands MedShape's existing NiTiNOL product portfolio, which includes the previously launched 2-leg DynaClip staple (2019) and DynaNail TTC Fusion System (2013).PR NewswireMedShape Receives $2.6M DOD Development Grant for Novel NiTiNOL Dynamic Compression DevicesMedShape, Inc. announced receipt of a $2.6 million Technology/Therapeutic Development Award from the Department of Defense Peer Reviewed Medical Research Program to develop dynamic compression fusion devices using superelastic NiTiNOL for diabetic foot limb salvage surgery. The three-year research grant will be conducted in collaboration with limb salvage specialists from the University of Arizona and Texas A&M College of Medicine, targeting the high failure rate (25-60%) of current midfoot fusion devices in diabetic Charcot patients. The technology leverages MedShape's existing patented NiTiNOL platform, which has already been clinically validated through the company's DynaNail TTC Fusion System.PR NewswireMedShape Announces Commercial Launch of DynaNail Mini™ for Subtalar FusionMedShape, Inc. announced the commercial launch of the DynaNail Mini™ Fusion System, the first orthopedic device specifically designed for subtalar fusion that uses patented superelastic nickel titanium (NiTiNOL) technology to maintain active compression post-surgery. The device represents an expansion of the DynaNail product line through successful miniaturization of the internal NiTiNOL Compressive Element while retaining dynamic compression performance. Early adoption by leading foot and ankle surgeons has shown positive outcomes, with the product to be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting in Chicago.PR NewswireThe DynaNail® TTC Fusion System Demonstrates Favorable Outcomes in Challenging Patient PopulationsMedShape, Inc. announced new clinical findings for its DynaNail® TTC Fusion System, published in the Journal of Foot & Ankle Surgery and Foot & Ankle Specialist. One study of 86 patients found DynaNail achieved fusion 3.9 months faster than nondynamized nails despite treating higher-risk patients, while another study of 33 patients reported a 90 percent fusion rate using conservative CT-based assessment. The company positions these studies as the strongest evidence to date of DynaNail's efficacy and superiority over competitor intramedullary nails for tibiotalocalcaneal arthrodesis.PR NewswireMedShape Announces Commercial Launch of DynaClip™ Bone StapleMedShape, Inc. announced the full commercial launch of its DynaClip Bone Fixation System, featuring patented superelastic nickel titanium (NiTiNOL) technology designed for foot and ankle surgical applications. The device offers dynamic compression and improved durability compared to existing staple designs through a broad bridge with thickened legs that distribute stress evenly. The DynaClip represents MedShape's second NiTiNOL-based product, following the 2013 launch of the DynaNail TTC Fusion System, and is provided sterile with consolidated disposable instrumentation in nine sizes.